Weight-Loss Surgery Linked to Rise in Fracture Risk

SATURDAY, June 4 (HealthDay News) -- The risk of fractures after weight-loss surgery may be even higher than previously thought, a new study suggests.

Excess Pounds May Lower Odds of Surviving Breast Cancer

SATURDAY, June 4 (HealthDay News) -- Breast cancer patients who were overweight or obese before and after the diagnosis have a lower chance of surviving, a new study suggests.

Could a Woman's Wrinkles Predict Risk of Fractures?

SATURDAY, June 4 (HealthDay News) -- As if facial wrinkles didn't have a bad enough rap, a new study suggests that the worse a woman's wrinkles are in early menopause, the lower her bone density.

Study Finds Ovarian Screening Tests Don't Improve Survival

SATURDAY, June 4 (HealthDay News) -- New research finds that the only two tests available to screen for ovarian cancer don't reduce the average woman's risk of dying from this "silent killer."

After Colon Cancer Surgery, Early Chemo May Pay Off

SATURDAY, June 4 (HealthDay News) -- For patients undergoing surgery for colorectal cancer, a new study suggests that the sooner chemotherapy starts following the operation, the better the prognosis.

Bone Drug Reduces Odds for Breast Cancer's Return: Study

FRIDAY, June 3 (HealthDay News) -- Early stage breast cancer patients can see their chances of the cancer's return drop by 32 percent when the osteoporosis drug Zometa is added to regular hormone therapy for three years after surgery, Austrian researchers report.

Officials: U.S. Not Affected by European E. Coli Outbreak

FRIDAY, June 3 (HealthDay News) -- U.S. health officials sought Friday to reassure Americans that there is little chance the deadly new strain of E. coli bacteria affecting Germany and other European countries will have any significant impact here.

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women

SATURDAY, June 4 (HealthDay News) -- The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found.

Cancer Drug Avastin Makes Inroads Against Ovarian Tumors

SATURDAY, June 4 (HealthDay News) -- Two new studies indicate that a common cancer drug, Avastin, may benefit both early stage ovarian cancer patients and women whose cancer has recurred.